OR-AIRSHIP
15.7.2020 15:02:11 CEST | Business Wire | Press release
Customer engagement company Airship today announced that it is launching a free version of Apptimize’s Feature Flags solution, enabling app developers to control the scope and timing of feature launches in order to validate success and reduce risk prior to full rollout. From new apps to those with massive audiences, developers can use Feature Flags by signing up for a free account , or take advantage of newly reduced pricing for unlimited Feature Flags from Apptimize.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200715005238/en/
The challenge with updating mobile apps is amplified by lengthy approval cycles required by the App Store and Google Play, which means new features either need to wait for the next update cycle or leverage suboptimal web views that lead to disjointed customer experiences. Apptimize Feature Flags allow companies like Quizlet, Stash and Western Union to maintain multiple branches of code within apps to gradually release new features to a small subset of users first — quickly rolling features back if needed, or fully deploying them as they are proven successful. This level of fine-grained control is vital in the competitive app environment, and is even more so now as businesses innovate with mobile to create new growth opportunities and revenue streams.
“To ensure the millions of students who use Quizlet’s learning app have the optimal experience and can study effectively, we run A/B testing on all new features before they are fully released which means a smooth process is essential to our success,” states Allen Pan, mobile engineer at Quizlet. “Apptimize is our go-to for A/B testing because its tools provide easy-to-use controls to test and validate different configurations, including their feature flags for rollouts, and the results are easy to read and integrate into our internal analytics platform.”
Whether it's new curbside pickup experiences, appointment booking processes, or implementing enhanced recommendations or social selling features, developers can use Apptimize Feature Flags to choose when and to whom new features are accessible, and easily turn them on or off. For example:
- VIP Customers: provide exclusive or first-access to a brand’s gold loyalty members
- By Location: different regions may have different expectations, requiring gradual rollout to 40 percent of users in Germany but only 10 percent of users in France as an example
- By Demographics: from high-value customers to gender, developers can set Feature Flags to control rollout to specific groups
- By Behavioral Segments: use custom groups to target feature rollout to users with different affinities, interests, or behaviors
According to a senior software engineer at The Western Union Company, “Before Apptimize, we couldn't control the rollout of features to specific markets, which was especially challenging as we manage multiple apps across the globe and had to wait for each of their app release cycles. Now we can ramp up, roll back or even schedule feature releases to launch across various countries and user segments, and with Apptimize's support have developed a common framework for our different apps to control feature releases and experimentation across multiple user segments.”
For more inspiration, download Airship’s “5 Ways to Use Feature Flags to Supercharge Your Mobile Growth,” or read a complimentary copy of Forrester Research, Inc.’s “The Life-Changing Magic Of Simplifying Your Mobile App,” April 23, 2020.
“Exceptional mobile-first experiences are more important than ever as companies strive to offer customers new levels of ease-of-use, convenience, and innovation that win their hearts and wallets,” said Brett Caine, CEO and president, Airship. “However, there are far too many businesses that maintain a ‘best guess’ and ‘fingers-crossed’ mentality that risks precious development resources, creates suboptimal user experiences, and jeopardizes hard-fought, expensive user acquisition efforts. We’ve now made it even easier — and free — for businesses to adopt feature release management and start reaping the rewards that optimization unlocks.”
In addition to feature release management, the Enterprise version of Apptimize offers unlimited multivariate testing. Marketers can launch experiments in minutes through its Visual Editor without coding or app updates, while developers can leverage programmatic testing for more complex experimentation with one-time configuration of dynamic variables that can be changed instantly to add new variants. These testing capabilities allow for the highest ROI when launching new features.
About Apptimize
Apptimize, an Airship company, is the most used multivariate testing and feature release management solution for mobile apps, also covering websites and OTT. Hundreds of leading global brands have gained advantage over competitors by creating amazing mobile experiences with Apptimize.
Now, together with Airship, marketers and product owners can now unify digital engagement and digital experimentation to optimize the entire customer journey end-to-end — from driving more testing participation to creating consistent and optimized experiences as customers move across messaging channels and digital properties.
Learn more about Apptimize by visiting its website , reading its blog or following it on Twitter or LinkedIn .
About Airship
Marketing and digital experience teams at thousands of the world’s most admired companies rely on Airship’s Customer Engagement Platform to create deeper connections with customers by delivering incredibly relevant, coordinated messages across channels.
Founded in 2009 as a pioneer in push notifications, Airship now gives brands the user-level data, engagement channels, AI orchestration and services they need to deliver push notifications, emails, SMS, in-app messages, mobile wallet cards and more to exactly the right person in exactly the right moment — building trust, boosting engagement, driving action and growing value.
Learn more about our Customer Engagement Platform , read our blog or follow us on Twitter , LinkedIn and Facebook .
View source version on businesswire.com: https://www.businesswire.com/news/home/20200715005238/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press release
- frontMIND study evaluating tafasitamab (Monjuvi®/Minjuvi®) in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL) selected for the prestigious Plenary Abstracts Session at EHA 2026 - Results showed tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) significantly prolonged progression-free survival (PFS), reducing risk of disease progression or death by 25% - Positive trends toward PFS benefit with Tafa-Len-R-CHOP were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypes - The frontMIND data support global regulatory applications for tafasitamab and lenalidomide in addition to R-CHOP for previously untreated DLBCL and HGBL Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified c
Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press release
Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til
IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press release
Venneman brings more than 30 years of digital transformation, AI, and enterprise technology experience as IQM prepares for its planned Nasdaq listing IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, s
DEWA Organises Second Agentic AI Retreat at Al Shera’a, World’s Tallest, Largest and Smartest Net‑Positive Government Building12.6.2026 17:08:00 CEST | Press release
HE Saeed Mohammed Al Tayer, MD & CEO of Dubai Electricity and Water Authority (DEWA),has emphasised that DEWA deploys the latest Agentic AI technologies, in line with the vision to enhance its leading role and reinforce Dubai’s position as the city of the future. He made these remarks during the Agentic AI Executive Retreat DEWA organised at Al Shera’a, its new headquarters, which is the world’s tallest, largest and smartest net-positive government building. The event was attended by the executive leadership team and key stakeholders in digital transformation and artificial intelligence (AI), as well as representatives from SAP and McKinsey. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612633834/en/ DEWA organises second Agentic AI Retreat at Al Shera’a, world’s tallest, largest and smartest net positive government building (Photo: AETOSWire) In his speech, Al Tayer said that DEWA is guided by directives from the wise l
BeOne Medicines’ Foundational Hematology Franchise Leads Next Era of B-Cell Cancer Innovation at EHA 202612.6.2026 12:00:00 CEST | Press release
Tacabrutideg (BGB-16673, BTK degrader) showed durable responses in heavily pretreated R/R CLL and BTK inhibitor–naïve patients, signaling potential for earlier lines of treatmentBRUKINSA plus sonrotoclax (ZS) delivered deep, durable responses and high uMRD rates across TN CLL and R/R MCL and CLL, reinforcing its potential as an all-oral, fixed-duration treatment BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from its foundational hematology franchise at the 2026 European Hematology Association (EHA) Congress in Stockholm. Updated results from tacabrutideg (BGB-16673), a potential best-in-class Bruton’s tyrosine kinase (BTK) degrader, demonstrated durable responses in pretreated relapsed/refractory (R/R) chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), with early activity also seen in BTK inhibitor–naïve patients. These data are complemented by results from the all-oral combination of BRUKINSA® (zanubru
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
